63 related articles for article (PubMed ID: 23856109)
1. [Cardiac involvement of the type I mucopolysaccharidosis].
Tian Z; Guo LL; Meng Y; Zhang SY; Zhu WL
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):197-9. PubMed ID: 23856109
[TBL] [Abstract][Full Text] [Related]
2. Cardiac manifestations of the mucopolysaccharidoses.
Schieken RM; Kerber RE; Ionasescu VV; Zellweger H
Circulation; 1975 Oct; 52(4):700-5. PubMed ID: 808361
[TBL] [Abstract][Full Text] [Related]
3. Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III.
Lin HY; Chen MR; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Orphanet J Rare Dis; 2019 Jun; 14(1):140. PubMed ID: 31196149
[TBL] [Abstract][Full Text] [Related]
4. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.
Braunlin EA; Berry JM; Whitley CB
Am J Cardiol; 2006 Aug; 98(3):416-8. PubMed ID: 16860035
[TBL] [Abstract][Full Text] [Related]
5. [Echocardiographic findings in 3 cases of mucopolysaccharidosis].
Fujiwara S; Miyamoto Y; Umemoto M; Fukuda K; Yokote Y; Nakamura Y; Masuyama Y
J Cardiogr; 1983 Mar; 13(1):171-80. PubMed ID: 6417249
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac manifestation of the mucopolysaccharidoses: periodical echocardiographic evaluation in six cases].
Tada A; Tanaka A; Yasuda M; Komatsu Y; Inoue E; Minamikawa H; Kozumi K; Yoshimura T; Ikuno Y; Oku H
J Cardiogr; 1983 Jun; 13(2):407-23. PubMed ID: 6427363
[TBL] [Abstract][Full Text] [Related]
7. The heart in the primary antiphospholipid syndrome.
Badui E; Solorio S; Martinez E; Bravo G; Enciso R; Barile L; Gutierrez-Vogel S; Miranda J
Arch Med Res; 1995; 26(2):115-20. PubMed ID: 7620275
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac involvement in mucopolysaccharidosis. Apropos of an echocardiographic study in 8 cases].
Ata J; Brigui M; Jerad T; Belkhiria N; Yacoub M; Harbi A; Essoussi AS
Ann Pediatr (Paris); 1991 Nov; 38(9):614-7. PubMed ID: 1750743
[TBL] [Abstract][Full Text] [Related]
9. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis.
Lin SM; Lin HY; Chuang CK; Lin SP; Chen MR
Mol Genet Metab; 2014 Apr; 111(4):493-8. PubMed ID: 24598247
[TBL] [Abstract][Full Text] [Related]
11. Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry.
Arn P; Wraith JE; Underhill L
J Pediatr; 2009 Jun; 154(6):859-64.e3. PubMed ID: 19217123
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: comment on pathogenesis of a novel complication.
Cabrera GH; Fernández I; Dominguez M; Clarke LA
Mol Genet Metab; 2012 Aug; 106(4):470-3. PubMed ID: 22732207
[TBL] [Abstract][Full Text] [Related]
13. [Echocardiographic manifestations of the heart in the Hunter syndrome: report of a case].
Hada Y; Lee Y; Sakamoto T; Amano K; Yamaguchi T; Ishimitsu T; Takenaka K; Takahashi H; Takikawa R
J Cardiogr; 1982 Dec; 12(4):1043-53. PubMed ID: 6821104
[TBL] [Abstract][Full Text] [Related]
14. Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.
Kampmann C; Lampe C; Whybra-Trümpler C; Wiethoff CM; Mengel E; Arash L; Beck M; Miebach E
J Inherit Metab Dis; 2014 Mar; 37(2):269-76. PubMed ID: 24062198
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic restrictive cardiomyopathy].
Nacruth R; Barretto AC; Mady C; da Luz PL; Pileggi F
Arq Bras Cardiol; 1993 Sep; 61(3):175-80. PubMed ID: 8110048
[TBL] [Abstract][Full Text] [Related]
16. High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry.
Arn P; Whitley C; Wraith JE; Webb HW; Underhill L; Rangachari L; Cox GF
J Pediatr Surg; 2012 Mar; 47(3):477-84. PubMed ID: 22424341
[TBL] [Abstract][Full Text] [Related]
17. The Ross procedure in children and young adults with congenital aortic valve disease.
Walters HL; Lobdell KW; Tantengco V; Lyons JM; Hudson CL; Struble SL; Hakimi M
J Heart Valve Dis; 1997 Jul; 6(4):335-42. PubMed ID: 9263860
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and characterization of cardiac involvement in Hunter syndrome.
Kampmann C; Beck M; Morin I; Loehr JP
J Pediatr; 2011 Aug; 159(2):327-31.e2. PubMed ID: 21529823
[TBL] [Abstract][Full Text] [Related]
19. Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II.
Lin HY; Chen MR; Lee CL; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Orphanet J Rare Dis; 2021 Feb; 16(1):99. PubMed ID: 33622387
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal findings of cardiac function in patients with systemic lupus erythematosus (author's transl)].
Köhler E; Boldt-Gäth A; Bremer G; Goeckenjan G; Lakomek HJ
Z Kardiol; 1982 Jan; 71(2):93-101. PubMed ID: 6461975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
